AtriCure | ATRC - 销售收入

金融业

USD

USD 676.64M

现金及等价物

USD 167.79M

USD 34.98M

USD 345.53M

USD 81.92M

USD 71.78M

股息收益率

0

USD 9.67M

USD 27.29M

1.3K

EPS每股收益

USD 0.18

股本和储备

USD 516.43M

USD 109.31M

债务利息支出

USD 1.21M

USD 1.25M

USD 61M

USD 1.97B

USD 8.96M

USD 143.94M

USD 9.67M

普通股股本

USD 50.64M

129.01

USD 394K

USD 153.6M

销售和管理费用

USD 82.56M

USD 83.93M

贸易债权人

USD 78.74M

应收帐款人

USD 79.98M

	销售	更改		日
Abbott	USD 12.59B		1.43B	2026-06
Artivion	USD 115.99M		2.6M	2025-12
AtriCure	USD 153.6M		12.4M	2026-06
Baxter International	USD 2.96B		260M	2026-06
Becton, Dickinson and Co.	USD 5B		300M	2026-06
Boston Scientific	USD 5.44B		240M	2026-06
Cooper Companies	USD 1.08B		57.4M	2026-03
Dexcom	USD 1.31B		120M	2026-06
Edwards Lifesciences	USD 1.74B		90M	2026-06
Globus Medical	USD 789.61M		29.76M	2026-06
Inogen	USD 74.93M		504K	2024-09
Insulet	USD 801.7M		40M	2026-06
Integra LifeSciences	USD 418.8M		26.9M	2026-06
Intuitive Surgical	USD 2.89B		120M	2026-06
J&J	USD 25.31B		1.21B	2026-06
Medtronic	USD 9.8B		800M	2026-03
Merit Medical Systems	USD 418.8M		36.9M	2026-06
ResMed	USD 1.46B		60M	2026-06
Stryker	USD 6.6B		600M	2026-06
Tandem Diabetes Care	USD 254.6M		7.38M	2026-06
Teleflex	USD 570.3M		22M	2026-06
Zimmer Biomet Holdings	USD 2.18B		90M	2026-06